Clinical Laserthermia Systems AB (publ) announced it has received an order for ClearPoint Prism? Neuro Laser Therapy System products from ClearPoint Neuro Inc. The order has a value of approximately SEK 8.1 million. CLS has a commercial collaboration with ClearPoint Neuro in neurosurgery aimed at developing and commercializing a fully integrated system for MRI image-guided stereotactic laser ablation with very high precision.

By offering a solution where both companies' technologies are integrated, the user can identify the target tissue, navigate and position the system's laser applicator, and monitor and control the ablation process in the target tissue with very high precision and accuracy. This order is part of ClearPoint Neuro's limited market release in North America and follows a previous order that CLS received in December 2023 of approximately SEK 2.4 million, bringing the total value of the latest deal to approximately SEK 10.5 million. The ClearPoint Prism?

Neuro Laser Therapy System enables integration with the ClearPoint neuro navigation platform and MRI scanners from leading manufacturers. The system is now being rolled out in the United States for use within neurosurgery.